NPSP INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of NPS Pharmaceuticals Inc. of Class Action Against the Board of the Company Concerning the Fairness of the Sale of the Company to Shire plc-- NPSP


NEW YORK, Jan. 29, 2015 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors of NPS Pharmaceuticals Inc. ("NPS Pharmaceuticals" or "the Company") (Nasdaq:NPSP) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to Shire plc. A complaint was filed in Delaware state court.

Click here to learn more about the action: http://zlk.9nl.com/nps-pharmaceuticals-npsp.

Under the terms of the transaction, NPS Pharmaceuticals shareholders will receive $46 in cash for each share of NPS Pharmaceuticals stock they own. The claims concern whether the Board of NPS Pharmaceuticals breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Shire plc is underpaying for NPS Pharmaceuticals shares.

If you own NPS Pharmaceuticals common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/nps-pharmaceuticals-npsp.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.



            

Contact Data